MULLIGAN BIOCAPITAL
Mulligan BioCapital is an investment firm dedicated to the life sciences with a specific focus on biotechnology with health care applications.
Investments List
| Date | Company | Article | Money raised |
|---|---|---|---|
| 2007-10-18 | DIREVO Industrial Biotechnology | Mulligan BioCapital investment in Series C - DIREVO Industrial Biotechnology | 16.8 M USD |
| 2005-09-19 | Spinal Cord Therapeutics GmbH | Mulligan BioCapital investment in Series A - Spinal Cord Therapeutics GmbH | 12.8 M EUR |
| 2004-03-17 | 4-Antibody AG | Mulligan BioCapital investment in Seed Round - 4-Antibody AG | 2.75 M CHF |
| 2003-05-21 | 4SC | Mulligan BioCapital investment in Series C - 4SC | 9 M EUR |
| 2002-09-23 | Cardion | Mulligan BioCapital investment in Venture Round - Cardion | 11.5 M EUR |
| 2000-12-18 | DIREVO Industrial Biotechnology | Mulligan BioCapital investment in Series A - DIREVO Industrial Biotechnology | 8.75 M EUR |
More informations about "Mulligan BioCapital"
Mulligan BioCapital - Investments, Portfolio & Company Exits
Oct 18, 2007 · Mulligan BioCapital is an investment firm dedicated to the life sciences with a specific focus on biotechnology with health careSee details»
Mulligan BioCapital Investor Profile: Portfolio & Exits - PitchBook
Information on investments, active portfolio, exits, fund performance, dry powder, team and co-investors for Mulligan BioCapital. Use the PitchBook Platform to explore the full profile.See details»
Mulligan BioCapital - Recent News & Activity - Crunchbase
Oct 18, 2007 · Mulligan BioCapital is an investment firm dedicated to the life sciences with a specific focus on biotechnology with health careSee details»
Mulligan BioCapital GmbH - Drug pipelines, Patents, Clinical trials ...
Explore Mulligan BioCapital GmbH with its drug pipeline, therapeutic area, technology platform, 4 news.See details»
Mulligan BioCapital GmbH - Company Profile and News
Mulligan BioCapital GmbH operates as a venture capital firm. The Company invests in biotechnology and health care sectors. Mulligan BioCapital serves customers in Germany.See details»
Mulligan BioCapital - Investor Profile, Portfolio & Team - Tracxn
Mulligan BioCapital - Life Science focused VC firm investing in Europe. Portfolio of 3 companies. 9 investors have invested with Mulligan BioCapital.See details»
Mulligan BioCapital - Investor Profile, Portfolio & Team - Tracxn
Mulligan BioCapital - Venture capital firm focused on biotech companies. Portfolio of 1 company. 3 investors have invested with Mulligan BioCapital.See details»
Mulligan BioCapital - Overview, News & Similar companies
Mulligan BioCapital contact info: Phone number: +49 40380816005 Website: www.mulliganbiocapital.com What does Mulligan BioCapital do? Mulligan BioCapital AG is an …See details»
Mulligan BioCapital - Investments, Portfolio & Exits - Tracxn
Mulligan BioCapital has a portfolio of 3 companies. Mulligan BioCapital - Investments, Portfolio & Exits - Tracxn JavaScript is disabled in your browser. enable it to enjoy the full features of Tracxn.See details»
Mulligan BioCapital - CoBee Company Profile & Funding Rounds
Mulligan BioCapital is an investment firm dedicated to the life sciences with a specific focus on biotechnology with health care applications.See details»
Mulligan BioCapital GmbH Company Profile - Dun & Bradstreet
Find company research, competitor information, contact details & financial data for Mulligan BioCapital GmbH of Bielefeld, Nordrhein-Westfalen. Get the latest business insights from Dun …See details»
Mulligan BioCapital - Investor, Germany - SWFI - Sovereign …
Mulligan BioCapital: Investor in Germany, Europe. Mulligan BioCapital is a Investor located in Germany, Europe. Request Profile Update; Download DataSee details»
Mulligan BioCapital GmbH, Bielefeld, Germany - North Data
Mulligan BioCapital GmbH, Bielefeld, Germany, District Court of Bielefeld HRB 42916: Total assets, Earnings, Revenue, Network, Financial informationSee details»
Mulligan BioCapital | Startup City Hamburg
Investment firm dedicated to the life sciences with a specific focus on biotechnology with health careSee details»
Mulligan BioCapital — 6 Investments, Performance analytics, Stats ...
Mulligan BioCapital. Search. Overview Investments Unlock datapoints. Portfolio analytics Team News & Media. Add fund to favorites. Save this fund for later to form your own custom list of …See details»
Mulligan BioCapital GmbH · Werner-Bock-Str. 23 ... - OpenCorpData
Mulligan BioCapital GmbH (LEI# 391200KCDSALIOTBBD32) is a legal entity registered with Bundesanzeiger Verlag GmbH. The address is Werner-Bock-Str. 23, Westefelhaus & Partner …See details»
Agenus Inc. completed the acquisition of 4-Antibody AG from …
Feb 11, 2014 · Agenus Inc. (NasdaqCM:AGEN) entered into a definitive agreement to acquire 4-Antibody AG from Advent Private Equity Fund IV managed by Advent Venture Partners, Life …See details»
Roland Oetker: Positions, Relations and Network - MarketScreener
Roland Oetker is the founder and the Managing Partner of ROI Verwaltungsgesellschaft mbH, which was founded in 1981. He is currently the Co-Managing Director of Mulligan BioCapital …See details»
Jens Klein AMSilk - SynBioBeta SF 2017
Oct 4, 2017 · Jens Klein is the Managing Director and CEO of AMSilk, the leading global producer of silk biopolymers and a pioneer in biofabrication. As CEO of AMSilk, Jens oversees strategy …See details»
Mulligan BioCapital - Tech Stack, Apps, Patents & Trademarks
Mulligan BioCapital is an investment firm dedicated to the life sciences with a specific focus on biotechnology with health careSee details»